BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 20064077)

  • 1. Biopharmaceutical drug targeting to the brain.
    Pardridge WM
    J Drug Target; 2010 Apr; 18(3):157-67. PubMed ID: 20064077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re-engineering biopharmaceuticals for delivery to brain with molecular Trojan horses.
    Pardridge WM
    Bioconjug Chem; 2008 Jul; 19(7):1327-38. PubMed ID: 18547095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reengineering biopharmaceuticals for targeted delivery across the blood-brain barrier.
    Pardridge WM; Boado RJ
    Methods Enzymol; 2012; 503():269-92. PubMed ID: 22230573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic engineering, expression, and activity of a fusion protein of a human neurotrophin and a molecular Trojan horse for delivery across the human blood-brain barrier.
    Boado RJ; Zhang Y; Zhang Y; Pardridge WM
    Biotechnol Bioeng; 2007 Aug; 97(6):1376-86. PubMed ID: 17286273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug targeting of erythropoietin across the primate blood-brain barrier with an IgG molecular Trojan horse.
    Boado RJ; Hui EK; Lu JZ; Pardridge WM
    J Pharmacol Exp Ther; 2010 Jun; 333(3):961-9. PubMed ID: 20233799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Trojan horses for blood-brain barrier drug delivery.
    Pardridge WM
    Curr Opin Pharmacol; 2006 Oct; 6(5):494-500. PubMed ID: 16839816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic engineering of a lysosomal enzyme fusion protein for targeted delivery across the human blood-brain barrier.
    Boado RJ; Zhang Y; Zhang Y; Xia CF; Wang Y; Pardridge WM
    Biotechnol Bioeng; 2008 Feb; 99(2):475-84. PubMed ID: 17680664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic engineering of a bifunctional IgG fusion protein with iduronate-2-sulfatase.
    Lu JZ; Hui EK; Boado RJ; Pardridge WM
    Bioconjug Chem; 2010 Jan; 21(1):151-6. PubMed ID: 20000684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new generation of neurobiological drugs engineered to overcome the challenges of brain drug delivery.
    Boado RJ
    Drug News Perspect; 2008 Nov; 21(9):489-503. PubMed ID: 19180267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humanization of anti-human insulin receptor antibody for drug targeting across the human blood-brain barrier.
    Boado RJ; Zhang Y; Zhang Y; Pardridge WM
    Biotechnol Bioeng; 2007 Feb; 96(2):381-91. PubMed ID: 16937408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective plasma pharmacokinetics and brain uptake in the mouse of enzyme fusion proteins derived from species-specific receptor-targeted antibodies.
    Zhou QH; Boado RJ; Pardridge WM
    J Drug Target; 2012 Sep; 20(8):715-9. PubMed ID: 22845843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor receptor-IgG fusion protein for targeted drug delivery across the human blood-brain barrier.
    Hui EK; Boado RJ; Pardridge WM
    Mol Pharm; 2009; 6(5):1536-43. PubMed ID: 19624167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GDNF fusion protein for targeted-drug delivery across the human blood-brain barrier.
    Boado RJ; Zhang Y; Zhang Y; Wang Y; Pardridge WM
    Biotechnol Bioeng; 2008 Jun; 100(2):387-96. PubMed ID: 18080333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood-brain barrier drug delivery of IgG fusion proteins with a transferrin receptor monoclonal antibody.
    Pardridge WM
    Expert Opin Drug Deliv; 2015 Feb; 12(2):207-22. PubMed ID: 25138991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug targeting to the brain.
    Pardridge WM
    Pharm Res; 2007 Sep; 24(9):1733-44. PubMed ID: 17554607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivery of Biologics Across the Blood-Brain Barrier with Molecular Trojan Horse Technology.
    Pardridge WM
    BioDrugs; 2017 Dec; 31(6):503-519. PubMed ID: 29067674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Trojan horses for blood-brain barrier drug delivery.
    Pardridge WM
    Discov Med; 2006 Aug; 6(34):139-43. PubMed ID: 17234133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted delivery of protein and gene medicines through the blood-brain barrier.
    Pardridge WM
    Clin Pharmacol Ther; 2015 Apr; 97(4):347-61. PubMed ID: 25669455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood-brain barrier molecular trojan horse enables imaging of brain uptake of radioiodinated recombinant protein in the rhesus monkey.
    Boado RJ; Hui EK; Lu JZ; Sumbria RK; Pardridge WM
    Bioconjug Chem; 2013 Oct; 24(10):1741-9. PubMed ID: 24059813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood-brain barrier delivery.
    Pardridge WM
    Drug Discov Today; 2007 Jan; 12(1-2):54-61. PubMed ID: 17198973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.